Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Seventure Partners

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 241
Average round size
info
The average size of a deal this fund participated in
$11M
Portfolio companies 168
Rounds per year 9.64
Lead investments 69
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.30
Exits 51
Key employees 9
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Software
  • Therapeutics
  • Pharmaceutical
Summary

Seventure Partners appeared to be the VC, which was created in 1997. The company was established in Europe in France. The main office of represented VC is situated in the Paris.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Seventure Partners, startups are often financed by Sofinnova Partners, Societe Generale Asset Management, Alven Capital. The meaningful sponsors for the fund in investment in the same round are XAnge, Sofinnova Partners, Omnes Capital. In the next rounds fund is usually obtained by Bpifrance, EASME - EU Executive Agency for SMEs, Auriga Partners.

For fund there is a match between the location of its establishment and the land of its numerous investments - France. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the most popular fund investment industries, there are Health Care, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight DayTwo, Launchmetrics, BIOMx.

The fund is generally included in 7-12 deals every year. The increased amount of exits for fund were in 2016. The average startup value when the investment from Seventure Partners is 10-50 millions dollars. The important activity for fund was in 2017. Despite it in 2019 the fund had an activity. Deals in the range of 5 - 10 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 16 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Seventure Partners performs on 2 percentage points less the average number of lead investments.

We also calculated 12 valuable employees in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Seventure Partners:
Typical Co-investors
Seventure Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Seventure Partners:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Clinical Microbiomics

Service Industry
$10M11 Oct 2022 Copenhagen, Hovedstaden, Denmark

Standing Ovation

Food and Beverage
$14M14 Sep 2022 Paris, Ile-de-France, France

Sentryc

B2B
Cyber Security
Intellectual Property
Privacy
Risk Management
$5M12 Jul 2022 Berlin, Berlin, Germany

Domain Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$46M10 May 2022 France, Grand Est, France

Tubulis

Biotechnology
Health Care
Life Science
Pharmaceutical
Therapeutics
$70M03 May 2022 Munich, Bavaria, Germany

BCD Bioscience

$12M13 Apr 2022 Davis, California, United States

Polaris

Biotechnology
Food and Beverage
$5M29 Mar 2022 Bretagne, Brittany, France

Geovelo

Information Technology
Mobile Apps
$4M15 Mar 2022 Tours, Centre-Loire Valley, France

Microbiotica

Biotechnology
Health Care
Therapeutics
$68M07 Feb 2022 Cambridge, England, United Kingdom
News
Dopavision Raises €12M in Series A Funding

– Dopavision, a Berlin, Germany-based company focused on development of digital therapeutics, raised €12M in Series A funding.
– The round was led by Seventure Partners with participation from Novartis Pharmaceuticals, Boehringer Ingelheim Venture Fund and Ababax Health.
– The new investment will be used for the clinical development of MyopiaX, its lead product in childhood myopia, activities to provide innovative digital treatments for children leveraging games, educational or cognitive training applications, and potentially broaden its pipeline to new indications.

Foodsmart Scores Over $25M

– Foodsmart, the personalized telenutrition and foodcare leader, has announced a Series C funding of more than $25m.
– The round was led by Advocate Aurora Enterprises, a newly launched subsidiary of Advocate Aurora Health, one of the largest health systems in the United States.
– Foodsmart’s Series C round also included participation from Mayfield Fund, Seventure Partners (Health for Life Capital), New Ground Ventures, Benefitfocus Founder Shawn Jenkins, Classpass CEO Fritz Lanman and former Darden Restaurants CEO Clarence Otis.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Seventure Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: